Research Article
[Retracted] Postoperative Adjuvant Chemoradiotherapy on the Survival of Stage III Gastric Cancer
Table 2
Comparison of acute adverse reactions between the two groups.
| Item | Myelosuppression | Gastrointestinal reactions | Neurotoxicity | Liver dysfunction |
| CT () | 1 | 20 | 16 | 17 | 13 | 2 | 8 | 11 | 10 | 16 | 3 | 5 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 1~5 | 31 (73.3%) | 27 (60%) | 27 (37.78%) | 29 (42.22%) | RCT () | 1 | 17 | 18 | 12 | 7 | 2 | 4 | 7 | 5 | 6 | 3 | 2 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 1-5 | 23 (85.1%) | 25 (92.6%) | 17 (62.9%) | 13 (48.1%) | | | 0.334 | 1.387 | 0.015 | 0.499 | | | 0.563 | 0.239 | 0.903 | 0.480 |
|
|
CT: chemotherapy; RCT: radiochemotherapy.
|